Corporate Finance Van Lanschot Kempen

Corporate Finance

Dedicated, independent, specialist service

Corporate Finance

Our Corporate Finance and Equity Capital Markets teams focus on four core sectors: life sciences & healthcare, European real estate, tech & fintech and infrastructure & renewables. Within these sectors, we’re not only intrinsically familiar with the companies and investors; we’re also up-to-date on the latest developments and trends. We generate insights that enable us to provide our clients with invaluable support when it comes to mergers & acquisitions, IPOs, equity capital markets and debt advisory services. Thanks to our independent advice and dedication to achieving results that exceed expectations, clients come back to us time and again. 

  • 1.

    Unique sector knowledge and expertise

    With our internationally operating sector teams and a global investor base, we have long-standing transaction experience in M&A, equity capital markets and debt advisory.
  • 2.

    Transparent and independent advice

    We build long-term client relationships, and run a straightforward product offering focusing uniquely on the needs of our clients.
  • 3.

    Long-term view with results-driven approach

    With good independent advice comes repeat business and long-term growth. Our results driven approach will help achieve high deal certainty for our clients.

Products and services

Benefit from our specialist sector knowledge with solutions tailored exclusively to corporate finance.

Mergers & acquisitions

For both listed and private companies, with extensive experience in sell-side and buy-side.

Equity Capital Markets

Advice on IPOs and other equity capital markets transactions, such as follow-on capital increases, secondary offerings, share buybacks and equity-linked transactions.

Private placements

For companies looking to access our global investor network for equity capital in a non-listed setting.

Active in the following sectors

European real estate

Transactions

Great cooperation makes for excellent transactions. Our outstanding sector knowledge combined with a strong focus on understanding stocks and companies ensures we have a superior industry network and distribution power, leading to a successful track record in the market. 

November 2024
transaction logo image
Sell-side public M&A
€219 million
62.78% stake in
Right Arrow in Circle

We could not have done this transaction, nor reached such an outcome, without the support of Van Lanschot Kempen. Their assistance in preparing and executing the transaction, as well as generating a significant amount of interest from their network, ensured a speedy and well-structured process with a very satisfactory outcome.

Pieter de Geus, Managing Director Sanquin Health Solutions, on the sale of Sanquin Reagents to Gilde Healthcare

Curious to know more?

Jan de Kerpel Van Lanschot Kempen

Jan De Kerpel

Managing Director
Life Sciences and Healthcare

Mail Jan de Kerpel

Thomas ten Hoedt Van Lanschot Kempen

Thomas ten Hoedt

Managing Director
European Real Estate
Compliance

Van Lanschot Kempen Corporate Finance and Equity Capital Markets

Regulatory schedule for professional and non-professional clients.
Download